Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome

Author:

El-Zimaity Maha M. T.,Kantarjian Hagop,Talpaz Moshe,O'Brien Susan,Giles Francis,Garcia-Manero Guillermo,Verstovsek Srdan,Thomas Deborah,Ferrajoli Alessandra,Hayes Kimberly,Nebiyou Bekele B.,Zhou Xian,Rios Mary B.,Glassman Armand B.,Cortes Jorge E.

Publisher

Wiley

Subject

Hematology

Reference43 articles.

1. Variant t(9;22) translocation may identify a subgroup of chronic myeloid leukemia patients with poor prognosis;Albano;Blood,2001

2. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148);Beran;Clinical Cancer Research,1998

3. The incidence, type, and subsequent evolution of 14 variant Ph1 translocations in 180 South African patients with Ph1-positive chronic myeloid leukemia;Bernstein;Cancer Genetics and Cytogenetics,1984

4. Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene: expression profiling, resistance to interferon therapy, and poor prognosis;Cohen;Cancer Genetics and Cytogenetics,2001

5. Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy;Cortes;Blood,2003a

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3